N-(3-ETHYNYLPHENYL-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE

The present invention relates to the anhydrous and hydrate forms of N-(3- ethynylphenyl)-6,7-bis (2-methoxyethoxy)4-quinazolinamine mesylate. The invention also relates to pharmaceutical compositions containing N- (3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate and to methods o...

Full description

Saved in:
Bibliographic Details
Main Authors ALLEN, DOUGLAS JOHN MELDRUM, SANTAFIANOS, DINOS PAUL, RAGGON, JEFFREY WILLIAM, NORRIS, TIMOTHY, SHANKER, RAVI MYSORE
Format Patent
LanguageEnglish
French
Published 30.06.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to the anhydrous and hydrate forms of N-(3- ethynylphenyl)-6,7-bis (2-methoxyethoxy)4-quinazolinamine mesylate. The invention also relates to pharmaceutical compositions containing N- (3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate and to methods of treating hyperproliferative disorders, such as cancer, by administering N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- quinazolinamine mesylate.
AbstractList The present invention relates to the anhydrous and hydrate forms of N-(3- ethynylphenyl)-6,7-bis (2-methoxyethoxy)4-quinazolinamine mesylate. The invention also relates to pharmaceutical compositions containing N- (3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate and to methods of treating hyperproliferative disorders, such as cancer, by administering N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- quinazolinamine mesylate.
Author ALLEN, DOUGLAS JOHN MELDRUM
NORRIS, TIMOTHY
SHANKER, RAVI MYSORE
RAGGON, JEFFREY WILLIAM
SANTAFIANOS, DINOS PAUL
Author_xml – fullname: ALLEN, DOUGLAS JOHN MELDRUM
– fullname: SANTAFIANOS, DINOS PAUL
– fullname: RAGGON, JEFFREY WILLIAM
– fullname: NORRIS, TIMOTHY
– fullname: SHANKER, RAVI MYSORE
BookMark eNrjYmDJy89L5WRI8NPVMNZ1DfGI9Iv0CfBwBZK6Zjrmuk6ewRpGur5ACf-ISAipqWuiGxjq6ecY5e8DJH09_VwVfF2DI30cQ1wVHP08Il2CICwXBV9_P38on4eBNS0xpziVF0pzM8i7uYY4e-imFuTHpxYXJCan5qWWxDs7GhkbG5iYmDsbE1YBAPAoNEw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ANHYDRATE ET MONOHYDRATE DE N-(3-ETHYNYLPHENYLAMINO)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE
ExternalDocumentID CA2330447C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2330447C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2330447C3
Notes Application Number: CA19992330447
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090630&DB=EPODOC&CC=CA&NR=2330447C
ParticipantIDs epo_espacenet_CA2330447C
PublicationCentury 2000
PublicationDate 20090630
PublicationDateYYYYMMDD 2009-06-30
PublicationDate_xml – month: 06
  year: 2009
  text: 20090630
  day: 30
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies PFIZER PRODUCTS INC
RelatedCompanies_xml – name: PFIZER PRODUCTS INC
Score 2.7367053
Snippet The present invention relates to the anhydrous and hydrate forms of N-(3- ethynylphenyl)-6,7-bis (2-methoxyethoxy)4-quinazolinamine mesylate. The invention...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title N-(3-ETHYNYLPHENYL-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090630&DB=EPODOC&locale=&CC=CA&NR=2330447C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR1dT8Iw8IJo1DdFDX7vwSyY2Ihb2bKHxYyuZBi2IQzDfMENuujLIDLj3_c2mPrCy-XaJk17zd31eh8FuKEJVWIlMkgy06Ykd62RCK0AoqqRMYtQKdA4z3d2Pc0Z0adxa1yB9zIXpqgT-l0UR0SOmiK_Z4W8Xvw9YtlFbOXyPv7ArvljJzBtubSOjbyElGy3Td73bZ_JjJnMkr2BqeR2O9XZFmzjJVrPg7_4SzvPSVn8VyidA9jp41xpdggVkdZgj5X_rtVg1127uxFdc97yCN480lAJD5zQC3t9hyMk2p1O2t1hQyEuDvjjcAVvCSXPo65nvfo9hG7X45LLh2HPCrhkeU5oD1aYLaFA9dftY7ju8IA5BJc6-aXKhFnlntQTqKbzVNRBoqqgzUgkLXUmqNoUhhFpD0LTExrhUYnpKdQ3zXK2eegc9ldOlDxM7gKq2eeXuERdnMVXBRl_AFVchxc
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf7MEsmNiIWxnuYTFjKxm6D4RhmC-4QRd9GURm_Pe9Daa-8HLpR3K5trler9f7FeCKxlSKpFAl8UyZkiy0RkL0Aogsh-osRKNAoyzf2XEVa0Qfx61xCd6LXJgcJ_Q7B0dEjZqivqf5fr34u8Qy87eVy9voA5vmD11fM8XCO1YzCCnR7Gis75meIRqGZuiiO9CkzG-nbWMLtvGAfZ-h7LOXTpaTsvhvULr7sNNHXkl6ACWeVKFiFP-uVWHXWYe7sbjWvOUhvLmkIRPmW4Eb2H2LISXKTZt0esOGRBzs8MbBil4TSp5HPVd_9WykTs9lgsOGga37TNBdKzAHq5Ip4IbqretHUO8y37AIijr5nZWJoRdjko-hnMwTXgOBypw2Qx635BmncpOraqjccaUd0xCXik9PoLaJy-nmrjpULN-xJyj00xnsrQIq2ZO5cyinn1_8Au1yGl3mU_oD05qKBw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=N-%283-ETHYNYLPHENYL-6%2C7-BIS%282-METHOXYETHOXY%29-4-QUINAZOLINAMINE+MESYLATE+ANHYDRATE+AND+MONOHYDRATE&rft.inventor=ALLEN%2C+DOUGLAS+JOHN+MELDRUM&rft.inventor=SANTAFIANOS%2C+DINOS+PAUL&rft.inventor=RAGGON%2C+JEFFREY+WILLIAM&rft.inventor=NORRIS%2C+TIMOTHY&rft.inventor=SHANKER%2C+RAVI+MYSORE&rft.date=2009-06-30&rft.externalDBID=C&rft.externalDocID=CA2330447C